Genomma Lab Internacional Financials
We strongly advise to harness Genomma Lab fundamental analysis to find out if markets are presently mispricing the company. Simply put you can make use of it to find out if Genomma Lab Internacional is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to break down and interpolate thirty-one available reported financial drivers for Genomma Lab Internacional, which can be compared to its competitors.
Genomma |
Understanding current and past Genomma Lab Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genomma Lab's financial statements are interrelated, with each one affecting the others. For example, an increase in Genomma Lab's assets may result in an increase in income on the income statement.
Genomma Lab Stock Summary
Genomma Lab competes with Hypera SA, Cumberland Pharmaceuticals, Orexo AB, C21 Investments, and Alpha Teknova. Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico. Genomma Lab operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 2327 people.Instrument | USA Pink Sheet View All |
Exchange | PINK Exchange |
Business Address | Av Antonio Doval |
Sector | Healthcare |
Industry | Drug Manufacturers—Specialty & Generic |
Benchmark | Dow Jones Industrial |
Website | www.genommalab.com |
Phone | 52 55 5081 0000 |
Currency | USD - US Dollar |
Genomma Lab Key Financial Ratios
There are many critical financial ratios that Genomma Lab's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Genomma Lab Internacional reports annually and quarterly.Return On Equity | 0.13 | |||
Return On Asset | 0.0921 | |||
Beta | 0.53 | |||
Last Dividend Paid | 0.38 |
Genomma Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genomma Lab's current stock value. Our valuation model uses many indicators to compare Genomma Lab value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genomma Lab competition to find correlations between indicators driving Genomma Lab's intrinsic value. More Info.Genomma Lab Internacional is rated below average in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genomma Lab Internacional is roughly 1.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genomma Lab's earnings, one of the primary drivers of an investment's value.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Genomma Pink Sheet
If you are still planning to invest in Genomma Lab Internacional check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genomma Lab's history and understand the potential risks before investing.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
CEOs Directory Screen CEOs from public companies around the world | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |